Basic Pletal Information

• INN (International Nonproprietary Name): Cilostazol
• Brand Names Available In Canada (English): Pletal — 100 mg tablets in bottles; generics labelled “cilostazol” are also available from multiple manufacturers.
• ATC Code: B01AC23
• Forms & Dosages: Tablets 100 mg, commonly packaged in bottles of 20, 30 or 56 tablets; 50 mg tablet form is rare and mainly seen in some Asian markets.
• Manufacturers In Canada (English): Original marketing holder Otsuka Pharmaceutical Co., Japan; generics supplied by various manufacturers and wholesalers; Canadian market listings normally show Otsuka as a registered supplier.
• Registration Status In Canada (English): Health Canada approved as a prescription-only medicine; both branded Pletal and generics with Health Canada DINs are present on the market.
• OTC / Rx Classification: Prescription Only Medicine (Rx) — not available over the counter in Canada.

Availability & Price Landscape

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Where can I pick up Pletal locally when my doctor prescribes it?

Shoppers Drug Mart, Rexall and London Drugs commonly dispense Pletal through their prescription aisles or by special order.

Stocking varies by store and depends on wholesalers and local demand, so a phone call before visiting is recommended.

Some stores keep Otsuka-branded Pletal on the shelf while others dispense a Health Canada–approved generic labelled “cilostazol.”

Quebec customers should check Jean Coutu and similar regional chains that may supply Pletal with French packaging.

• Shoppers Drug Mart: In-store pickup and prescription transfer options.
• Rexall: Special-order channels and pharmacy counselling at pickup.
• London Drugs: Regional stocking with online refill options.
• Jean Coutu (Quebec): French-labelled packaging and local formulary support.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

How do online pharmacies handle Pletal prescriptions across provinces?

Canadian e-pharmacies increasingly list cilostazol but will always require a valid prescription for dispensing.

Many e-shops verify prescriptions electronically and will not ship to provinces with restrictive import rules or where the product lacks a Canadian DIN.

Cross-border behaviour persists; some patients compare U.S. pricing or source generics from European e‑pharmacies, but customs checks and Health Canada import rules make this a riskier option.

When ordering online, confirm the listed product has a Health Canada DIN or is clearly labelled with manufacturer and pack size to avoid unregistered imports.

Price Ranges By Package Size (With Provincial Differences)

What should I expect to pay out-of-pocket for Pletal in Canada?

Typical retail pricing varies by bottle size and by province, with larger packs offering a lower per-tablet cost.

Provincial drug plans such as ODB (Ontario), BC PharmaCare and RAMQ (Quebec) may cover cilostazol under specific criteria with differing copays and requirements for prior therapies.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

What are Canadians saying online about pletal?

Discussions on Reddit communities like r/CanadaHealth and r/AskDocs, on HealthBoards and local Facebook groups commonly cover symptom changes, side effects and access hurdles.

Many posts describe needing a few weeks before noticing any benefit, and posters often compare experiences with physician advice.

Reported Benefits And Challenges From Canadian Patients

Does Pletal help walking distance and daily life?

Patients who respond well commonly report improved walking distance for intermittent claudication after several weeks, with some seeing early changes by 2–4 weeks and fuller benefit by 12 weeks.

Commonly reported side effects in Canadian threads mirror Health Canada safety information and include headaches, palpitations, diarrhoea and transient dizziness.

Several posters note pharmacies requiring prior authorization, challenges finding branded stock and price differences between branded Pletal and generics.

Satisfaction trends are mixed: those with symptom improvement often rate the drug highly, while patients experiencing side effects or with cardiac comorbidities often discontinue early.

Peer advice frequently recommends checking for drug interactions (CYP3A4/CYP2C19 inhibitors), confirming absence of heart failure, and verifying provincial coverage before filling.

• Quick Quote: “I could walk farther after a few weeks, but the headaches were real for the first month.”
• Quick Quote: “My pharmacy asked for prior authorization and substituted a generic — cost was different.”

• Patient Terms
• Intermittent Claudication: Pain in the legs on walking due to reduced blood flow.
• Formulary: Provincial drug list that determines coverage rules.
• Prior Authorization: Additional paperwork required by some plans to approve coverage.

Product Overview & Brand Variants

INN And Brand Names Used In Canada

What names will Pletal appear under in Canadian listings?

The active ingredient is cilostazol (INN: cilostazol) and the marketed brand in Canada is Pletal in 100 mg tablet bottles.

Generics labelled “cilostazol” are also available from various manufacturers and wholesalers in Canada.

Legal Classification Under Health Canada

How is Pletal regulated in Canada?

Pletal is classified as a Prescription-Only Medicine (Rx) under Health Canada and each marketed product carries a Drug Identification Number (DIN) confirming regulatory approval and product specifics.

Otsuka is listed as the original marketing holder in Canada, while generics come from multiple suppliers.

Product Specifications

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

What is Pletal approved to treat in Canada?

Health Canada approves cilostazol for the treatment of intermittent claudication due to peripheral arterial disease, consistent with DIN labelling.

Clinicians typically advise a trial period with reassessment at 2–4 weeks and discontinuation if no benefit by approximately 12 weeks.

Off-Label Patterns In Canadian Healthcare

Is Pletal used for anything else in Canada?

Off-label use of cilostazol in Canada is uncommon and generally discouraged because evidence outside intermittent claudication is limited.

Occasional literature cites nonstandard uses such as adjunct microvascular strategies, but these are not routine practice and lack robust evidence.

Provincial formularies commonly require documented PAD diagnosis and evidence of prior therapy attempts, such as supervised exercise or trial of pentoxifylline, before coverage is approved.

• Checklist For Formulary Reimbursement:
• Documented diagnosis of peripheral arterial disease with intermittent claudication.
• Record of prior conservative therapies (exercise program, smoking cessation).
• Clinical notes showing need for pharmacologic therapy and expected outcomes.

How It Works In The Body

Layman’s Explanation (Canadian Patient-Friendly Tone)

What does Pletal do to help my legs?

Cilostazol is a tablet that reduces platelet stickiness and gently widens small blood vessels, which improves blood flow to leg muscles and helps reduce pain when walking.

The effect builds over several weeks, so patience is usually required to see the full benefit.

Clinical Detail From Health Canada Resources

How does cilostazol work at the biochemical level?

Cilostazol is a phosphodiesterase III (PDE III) inhibitor that increases cyclic AMP levels in platelets and blood vessels, producing antiplatelet and vasodilatory effects.

Clinically, PDE III inhibition reduces platelet aggregation and causes mild vasodilation, with benefit typically emerging over weeks and peaking around 12 weeks.

Because of cardiovascular effects tied to the drug class, cilostazol is contraindicated in any degree of heart failure (NYHA I–IV).

• Mechanism Flow: PDE III Inhibition → ↑ cAMP in Platelets & Vessels → ↓ Platelet Aggregation + Vasodilation → Improved Muscle Perfusion → Increased Walking Distance.

• Glossary
• PDE III: Enzyme that breaks down cyclic AMP in platelets and vessel walls.
• cAMP: Cellular messenger that mediates vasodilation and reduced platelet stickiness.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

What is the usual dose for adults in Canada?

The standard adult dose is 100 mg orally twice daily, taken 30 minutes before or at least 2 hours after meals.

Prescribers expect an initial reassessment at 2–4 weeks and an efficacy evaluation by 12 weeks to decide whether to continue therapy.

Adjustments By Patient Type (With Canadian Clinical Notes)

Do elderly or impaired patients need different dosing?

Elderly patients do not routinely require dose reduction but should be monitored closely for side effects such as headache, tachycardia and dizziness.

Cilostazol is contraindicated in moderate to severe hepatic impairment and should be used cautiously in severe renal impairment because adverse events may increase.

Strong CYP3A4 or CYP2C19 inhibitors can raise cilostazol levels and warrant close monitoring or consideration of alternative therapy.

• Monitoring Checkpoints:
• Assess walking distance and symptom change at 2–4 weeks.
• Review heart history and report any palpitations or syncope immediately.
• Evaluate overall benefit by 12 weeks and stop if no improvement.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Who should not take Pletal?

Absolute contraindications include any degree of heart failure (NYHA I–IV) and moderate to severe hepatic impairment.

Known hypersensitivity to cilostazol or any excipient is also an absolute contraindication.

Common adverse effects listed by Health Canada include headache, diarrhoea, abnormal stools, palpitations or tachycardia, dizziness and peripheral oedema.

• Headache
• Diarrhea
• Abnormal stools
• Palpitations / Tachycardia
• Dizziness
• Peripheral Edema

Rare But Serious (With Canadian Pharmacovigilance Data)

What serious problems should patients watch for?

Rare but serious events include arrhythmias, significant hypotension, major bleeding in high-risk patients and severe hepatic reactions.

Canadian pharmacovigilance highlights the need for careful cardiovascular screening before starting cilostazol.

Advise patients to seek immediate medical attention for chest pain, syncope, severe palpitations or signs of serious bleeding.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Pros And Cons List

• Cilostazol / Pletal: Generally more effective at improving walking distance than pentoxifylline, but carries cardio-related contraindications and common side effects such as headache and palpitations.
• Pentoxifylline: Different adverse-event profile (gastrointestinal, dizziness) and often less functional gain, but fewer cardiac contraindications.
• Generics: Bioequivalent when approved by Health Canada; check DIN and manufacturer details for each product.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

What does recent research say about cilostazol?

Recent trials and observational studies from 2022 to 2025 focus on long-term outcomes, subgroup effects in older adults and safety signals relating to heart failure risk.

International trials continue to show modest functional gains for intermittent claudication with cilostazol compared to placebo or pentoxifylline, while Canadian registry analyses stress careful patient selection due to cardiac contraindications.

Ongoing research explores cilostazol’s effects on endothelial function and microvascular perfusion, and real-world data projects analyse adherence and tolerability in community settings.

Key practical point for clinicians and pharmacists: the expected timeline for effectiveness is up to 12 weeks, and unresolved questions include optimal duration beyond three months and comparative outcomes in frail elderly patients.

• Annotated Bibliography: See provincial registry reports and recent meta-analyses for detailed trial data and subgroup analyses.

Common Patient Questions In Canada

Frequently Asked Questions

Is Pletal covered by provincial drug plans?

Some provincial plans cover cilostazol under specific criteria; check ODB (Ontario), BC PharmaCare and RAMQ (Quebec) for program details and prior authorization requirements.

Do I need a new prescription to order?

A prescription is required for lawful dispensing; many pharmacies accept electronic prescriptions.

How long before I notice improvement?

Initial benefits may appear at 2–4 weeks, with full effect often taking up to 12 weeks.

Can I take it with my heart medications?

Not if you have heart failure; review all medications for interactions, particularly strong CYP3A4 or CYP2C19 inhibitors which can increase cilostazol levels.

Is generic cilostazol as good as the brand?

Yes; Health Canada–approved generics contain the same INN and must meet regulatory standards; verify the DIN and manufacturer on the product page.

What should I do about side effects?

Report mild side effects to your pharmacist or prescriber; seek immediate care for chest pain, syncope, severe palpitations or active bleeding.

Regulatory Status

Health Canada Approval Process

How was Pletal approved and what does that mean for patients?

Health Canada evaluates safety, efficacy and product quality before issuing a DIN for legally marketed prescription drugs.

Post-marketing surveillance through Canada Vigilance monitors adverse events after approval.

DIN Number Relevance

Why is the DIN important when buying Pletal?

The DIN identifies the exact marketed product and allows verification of regulatory approval, formulation and manufacturer details.

When sourcing generics or ordering online, ensure the product has a Health Canada DIN to avoid unregistered imports.

Visual Recommendations

Infographic Ideas For Canadian Context

What visuals help patients and clinicians quickly understand Pletal?

Recommended visuals include a product-at-a-glance card showing DIN, strength, pack sizes, manufacturer and price.

A mechanism infographic illustrating PDE III inhibition leading to increased blood flow and improved walking distance is helpful for patient education.

A timeline graphic that shows expected response at 2–4 weeks and up to 12 weeks for full effect assists expectations management.

Use a prominent contraindication badge for heart-failure warning and a provincial coverage map showing ODB, BC PharmaCare and RAMQ links where applicable.

Ensure bilingual labels for Quebec audiences and accessibility features such as alt text and readable fonts.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

Should I buy Pletal in-store or online?

Always have a valid prescription when purchasing Pletal in Canada because it is a prescription-only medicine per Health Canada.

In-store pickup at Shoppers, Rexall, London Drugs and Jean Coutu ensures pharmacist counselling and immediate queries about side effects or interactions.

Online Canadian pharmacies can deliver nationwide but require prescription verification and may restrict shipping to some provinces.

Compare in-store and online prices, but validate the product DIN and manufacturer before purchase to ensure a Health Canada–approved product.

Note: Pletal is prescription-only in Canada; however, in our online pharmacy, pletal is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Proper Storage With Canadian Climate Considerations

How should I store Pletal at home and on the go?

Store at room temperature, ideally between 15–30°C, in a dry place and in its original container so lot and DIN information remain available.

Avoid leaving bottles in vehicles where Canadian summer heat or winter cold can damage the tablets.

For travel, carry the labelled original container and a copy of your prescription or pharmacist note.

• DO: Keep in original bottle, away from moisture and extreme temperatures.
• DO NOT: Store in the bathroom or leave in a hot car during summer months.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

What will the pharmacist tell me when dispensing Pletal?

Confirm diagnosis of PAD and absence of heart failure before dispensing or counselling on cilostazol.

Review the patient’s full medication list for strong CYP3A4 and CYP2C19 inhibitors and discuss potential interactions.

Explain the dosing schedule: 100 mg twice daily, taken 30 minutes before or at least 2 hours after food, and the typical onset timeline of 2–12 weeks.

Ask patients to report palpitations, syncope, severe headache or signs of bleeding immediately.

Recommend concurrent supervised exercise therapy and smoking cessation as standard components of PAD management.

Record DIN, lot number and counselling notes in the pharmacy record and provide required documentation if the patient requests a provincial coverage submission.

• Short Counselling Script: “This medicine is cilostazol, 100 mg twice daily. Take it 30 minutes before meals or two hours after. Expect initial changes in two to four weeks and reassess at twelve weeks. Stop and call us or seek urgent care if you have chest pain, fainting or severe palpitations.”

Delivery Across Canada (English)

Final Notes And Next Steps

If you are considering pletal, check whether your provincial drug plan requires prior authorization and prepare documentation showing PAD diagnosis and prior conservative therapies.

Ask your pharmacist to perform a medication review for CYP3A4 and CYP2C19 interactions before you start cilostazol.

Expect to follow up with your prescriber at about two to four weeks for tolerability and again around 12 weeks for efficacy assessment.

Keep the product bottle with the DIN and lot number for any future queries or adverse-event reports.

For any acute cardiac symptoms or serious side effects, stop the medication and seek immediate medical attention.